Sino-Singapore Health丨 Representative members focus on "Three Medical Synergies": How can the pharmaceutical industry develop with high quality?

"Advice·Mission" The 4th (2024) Chongqing Pharmaceutical Industry People's Congress Deputies and CPPCC Members Symposium was held in Chongqing.

Photo by Ma Jiaxin

　　China News Service, Chongqing, January 18 (Ma Jiaxin) How should the "three medicines" of medical care, medical insurance, and medicine be linked?

How can Chongqing's pharmaceutical industry achieve high-quality development under the reform, innovation and policy environment of the "three-medicine synergy" system and mechanism?

On the 17th, the fourth (2024) Chongqing Pharmaceutical Industry People’s Congress Deputies and CPPCC Members Symposium “Advice and Mission” was held in Chongqing.

Chongqing Municipal People's Congress deputies, CPPCC members, and industry representatives focused on the reform and innovation of the "three-medicine synergy" system and mechanism to speed up the high-quality development of the pharmaceutical industry and provide suggestions.

　　"The biopharmaceutical industry involves research, production, learning and application, and every link must be connected." You Hongtao, deputy to the Chongqing Municipal People's Congress and chairman of Chongqing Huasen Pharmaceutical Co., Ltd., said that Chongqing is not well linked in this regard.

For example, Chongqing's biopharmaceutical industry has not yet formed a closed loop from research and development to production and use. Local medical institutions have information asymmetry, and the local transformation of new drugs developed is not ideal.

　　You Hongtao suggested that associations, hospitals, enterprises, etc. should work together to form a closed loop and create a good environment for the biomedical industry.

The Chengdu-Chongqing twin-city economic circle also needs to be linked. The markets and experiences of Sichuan and Chongqing need to be mutually recognized. Drug bidding, management, price, research and development, use, etc. also need to interact.

In addition, companies should seize the opportunity to work together to make Chongqing's biopharmaceutical industry bigger and stronger.

　　Peng Xueping, deputy to the Chongqing Municipal People's Congress and chairman of Xueping Health Industry Group Co., Ltd., suggested that the pan-medical consortium digital hospital service system should be more widely applied, actively practice the collaborative application development of the three hospitals, and break the composition and operation of the traditional medical consortium in the past. model, the out-of-hospital pharmacies, clinics, nursing homes, health examination centers, school and enterprise clinics, insurance company medical management centers, etc. of tertiary hospitals will be included in the construction and certification of the pan-medical consortium digital hospital service system, and a distributed system will be built for tertiary hospitals. A global digital business system deployed in a mesh manner.

　　“The innovative traditional Chinese medicine industry has a wide scope and a long chain, involving almost the entire process of primary, secondary, and tertiary industries, covering medicinal material cultivation, traditional Chinese medicine production, traditional Chinese medicine, medical care, health care, health care for the elderly, health tourism, health food and other fields. Yue Lin, deputy to Chongqing Municipal People's Congress and chairman of Southwest Digital Pharmaceutical Group, suggested that we should actively promote cooperation and innovation in all aspects of the industrial chain, continuously build a value ecosystem for the traditional Chinese medicine industry, and continue to promote traditional Chinese medicine seed processing and traditional Chinese medicine through mutual empowerment and common growth. The comprehensive integration of industrial chains such as material research and development, traditional Chinese medicine wellness tourism, and traditional Chinese medicine cultural dissemination will help the traditional Chinese medicine industry form a good trend.

　　Digital transformation is an important strategic initiative for pharmaceutical companies, which can help companies improve efficiency, quality and competitiveness.

Yu Min, a representative of the Chongqing Municipal People's Congress and general manager of Taiji Group, said that from medicinal material production, scientific research to marketing, traditional Chinese medicine must be connected throughout the entire industry chain, and he hopes that Chongqing can create a digitalization of the entire traditional Chinese medicine industry chain.

　　"Chongqing biomedicine started relatively late nationwide, and has gradually formed a 1+5+N industrial model in recent years." Xian Ya, member of the Chongqing CPPCC and Secretary of the Party Committee of Southwest Pharmaceutical Co., Ltd., put forward three suggestions. The first is to encourage collaborative research between medical industry, academia and research, aiming at the key node of innovation and reform. The second is to accelerate the research and development of innovative drugs and strengthen the investment and financing market in Chongqing’s biomedical industry. The third is to strive to create a biomedical segment competition with differentiated competitive advantages. industrial park.

(over)